/IRME
IRME Stock - IR-Med Inc.
Healthcare|Medical - DevicesOTC
$0.04+86.05%
+$0.02 (+86.05%) • Dec 19
46
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.35
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.12
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.04
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for IRME
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.04 – $0.04
TARGET (TP)$0.05
STOP LOSS$0.04
RISK/REWARD1:Infinity
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.70
52W High$0.74
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-21,000 | $-17,000 | $-10,000 | $-5,000 | $-1,000 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-1,941,000 | $-4,911,000 | $-4,762,000 | $-3,675,000 | $-730,000 |
| Net Income | $-1,899,000 | $-4,909,000 | $-9,462,000 | $-3,721,000 | $-761,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.03 | $-0.07 | $-0.14 | $-0.06 | $-0.03 |
Company Overview
IR-Med Inc., a development stage medical device company, focuses on the development of infra-red light spectroscopy combined with artificial intelligence technology platform to address diagnostic or medical needs. It is developing PressureSafe, a handheld optical monitoring device to support early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear infection (Otitis Media), a common malady in children. The company is headquartered in Rosh Pina, Israel.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
IRMEBeat Rate
29%
Last 7 quarters
Avg Surprise
+8.0%
EPS vs Estimate
Beats / Misses
2/0
5 met exactly
Latest EPS
$-0.01
Q3 2025
EPS Surprise History
Q4 23
0.0%
$-0.02vs$-0.02
Q2 24
0.0%
$-0.02vs$-0.02
Q2 24
+6.1%
$-0.01vs$-0.01
Q3 24
0.0%
$-0.01vs$-0.01
Q4 24
0.0%
$-0.01vs$-0.01
Q2 25
+50.0%
$-0.01vs$-0.02
Q2 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 14, 2025 | — | $-0.01 | — | — |
Q2 2025 | May 15, 2025 | — | $-0.01 | — | — |
Q2 2025 | Apr 4, 2025 | $-0.02 | $-0.01 | +50.0% | ✓ BEAT |
Q4 2024 | Nov 14, 2024 | $-0.01 | $-0.01 | 0.0% | = MET |
Q3 2024 | Aug 13, 2024 | $-0.01 | $-0.01 | 0.0% | = MET |
Q2 2024 | May 13, 2024 | $-0.01 | $-0.01 | +6.1% | ✓ BEAT |
Q2 2024 | Apr 1, 2024 | $-0.02 | $-0.02 | 0.0% | = MET |
Q4 2023 | Nov 14, 2023 | $-0.02 | $-0.02 | 0.0% | = MET |
Q3 2023 | Aug 14, 2023 | $-0.02 | $-0.02 | 0.0% | = MET |
Q2 2023 | May 15, 2023 | — | $-0.02 | — | — |
Q1 2023 | Mar 29, 2023 | — | $-0.03 | — | — |
Q4 2022 | Nov 14, 2022 | — | $-0.01 | — | — |
Q3 2022 | Aug 15, 2022 | — | $-0.01 | — | — |
Q2 2022 | May 16, 2022 | — | $-0.04 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.02 | — | — |
Q4 2021 | Nov 15, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.02 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.01 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about IRME
What is IRME's current stock price?
IR-Med Inc. (IRME) is currently trading at $0.04 per share. The stock has moved +86.05% today.
What is the analyst price target for IRME?
No analyst price targets are currently available for this stock.
What sector is IR-Med Inc. in?
IR-Med Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is IRME's market cap?
IR-Med Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does IRME pay dividends?
No, IR-Med Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorLLBO
Lifeline Biotechnologies, Inc.
$0.00
Mkt Cap: $0.0B
LMLLF
Pharmadrug Inc.
$0.01
Mkt Cap: $0.0B
PLLWF
Polarean Imaging plc
$0.00
Mkt Cap: $0.0B
RMSL
REMSleep Holdings, Inc.
$0.00
Mkt Cap: $0.0B
RVVTF
Revive Therapeutics Ltd.
$0.01
Mkt Cap: $0.0B
SIGY
Sigyn Therapeutics, Inc.
$1.71
Mkt Cap: $0.0B
SLDX
Stella Diagnostics Inc.
$0.03
Mkt Cap: $0.0B
STHZF
StateHouse Holdings Inc.
$0.00
Mkt Cap: $0.0B
TBRIF
Therma Bright Inc.
$0.04
Mkt Cap: $0.0B
TLIS
Talis Biomedical Corporation
$2.84
Mkt Cap: $0.0B
Explore stocks similar to IRME for comparison